This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bray, J. S. Search for Related Content PubMed PubMed Citation Articles by Bray, J. S. Social Bookmarking                         What's this?

Safety Profile of Bevantolol

Double-blind and long-term open-label studies have demonstrated a remark ably favorable safety profile for bevantolol. The drug was associated with a low incidence of adverse experiences similar to that observed with placebo. The adverse experiences were mostly mild to moderate and of the types found previ ously for other beta-blocking drugs. Very few patients withdrew from clinical studies because of adverse effects. Some patients continued on study for over four years. Bevantolol offers safe beta-blocking activity for the long-term treat ment of angina and hypertension.

Angiology, Vol. 37, No. 3, 248-253 (1986)
DOI: 10.1177/000331978603700318


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?